BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20018680)

  • 1. A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.
    McMullin RP; Dobi A; Mutton LN; Orosz A; Maheshwari S; Shashikant CS; Bieberich CJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):98-103. PubMed ID: 20018680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis.
    McMullin RP; Mutton LN; Bieberich CJ
    Dev Dyn; 2009 Mar; 238(3):664-72. PubMed ID: 19191217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.
    Rao V; Heard JC; Ghaffari H; Wali A; Mutton LN; Bieberich CJ
    Prostate; 2012 Jul; 72(10):1045-51. PubMed ID: 22297979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
    Gao N; Zhang J; Rao MA; Case TC; Mirosevich J; Wang Y; Jin R; Gupta A; Rennie PS; Matusik RJ
    Mol Endocrinol; 2003 Aug; 17(8):1484-507. PubMed ID: 12750453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
    Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
    Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.
    Gao N; Ishii K; Mirosevich J; Kuwajima S; Oppenheimer SR; Roberts RL; Jiang M; Yu X; Shappell SB; Caprioli RM; Stoffel M; Hayward SW; Matusik RJ
    Development; 2005 Aug; 132(15):3431-43. PubMed ID: 15987773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes.
    Huang L; Pu Y; Hepps D; Danielpour D; Prins GS
    Endocrinology; 2007 Mar; 148(3):1235-45. PubMed ID: 17138648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
    Sun Q; Yu X; Degraff DJ; Matusik RJ
    Mol Endocrinol; 2009 Dec; 23(12):2038-47. PubMed ID: 19846536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.
    DeGraff DJ; Grabowska MM; Case TC; Yu X; Herrick MK; Hayward WJ; Strand DW; Cates JM; Hayward SW; Gao N; Walter MA; Buttyan R; Yi Y; Kaestner KH; Matusik RJ
    Lab Invest; 2014 Jul; 94(7):726-39. PubMed ID: 24840332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis.
    Stelloo S; Nevedomskaya E; Kim Y; Hoekman L; Bleijerveld OB; Mirza T; Wessels LFA; van Weerden WM; Altelaar AFM; Bergman AM; Zwart W
    Oncogene; 2018 Jan; 37(3):313-322. PubMed ID: 28925401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.
    VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ
    Elife; 2020 Jun; 9():. PubMed ID: 32553107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells.
    Jägle S; Busch H; Freihen V; Beyes S; Schrempp M; Boerries M; Hecht A
    PLoS Genet; 2017 Nov; 13(11):e1007109. PubMed ID: 29155818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
    Hankey W; Chen Z; Wang Q
    Cancer Res; 2020 Jun; 80(12):2427-2436. PubMed ID: 32094298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An endoderm-specific transcriptional enhancer from the mouse Gata4 gene requires GATA and homeodomain protein-binding sites for function in vivo.
    Rojas A; Schachterle W; Xu SM; Black BL
    Dev Dyn; 2009 Oct; 238(10):2588-98. PubMed ID: 19777593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate.
    Economides KD; Capecchi MR
    Development; 2003 May; 130(10):2061-9. PubMed ID: 12668621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioneer of prostate cancer: past, present and the future of FOXA1.
    Teng M; Zhou S; Cai C; Lupien M; He HH
    Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The homeodomain protein HOXB13 regulates the cellular response to androgens.
    Norris JD; Chang CY; Wittmann BM; Kunder RS; Cui H; Fan D; Joseph JD; McDonnell DP
    Mol Cell; 2009 Nov; 36(3):405-16. PubMed ID: 19917249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
    Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
    Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.